NEFL and Alzheimer disease: Of the biomarker values that did not undergo correction, YKL40, GFAP, NfL, neurogranin, pTau, and tTau were all increased in patients with AD-dementia or MCI who were A+ compared with CU individuals and patients with MCI who were A−.